High diagnosis rate in developed economies supporting the leukemia therapeutics market growth

Image Credit : empowher

According to the Centre for Disease Control (CDC), around 14.1 million people were diagnosed with cancer in 2012, resulting in around 8.2 million fatalities. Around 19.3 million new cases of cancer are projected to be diagnosed by 2025. Leukemia cases are projected to be more in the developed economies such as North America and Europe, owing to genetic mutations caused by radiation exposure. There are about 54,270 new cases of leukemia in the U. S. annually. Leukemia makes up about 3% of all new cancer cases. According to the World Cancer Research Fund, one third of the cancer cases occur in economically developed economies such as US and Europe, owing to lack of physical activity, obesity, and/or poor nutrition. Furthermore, around 90% of the leukemia occur in the middle age and develop with the aging.

To get holistic SAMPLE of the report, please click: https://www.coherentmarketinsights.com/insight/request-sample/528

Furthermore, in emerging economies of Asia Pacific such as China and India, the leukemia therapeutics market is expected to grow at significant rate due high unmet medical needs. However, low diagnosis rate of leukemia and lack of proper healthcare facilities in few Asian and African countries is restraining growth of the leukemia therapeutics market in these regions.

Leukemia also known as blood cancer hinders ability of an individual to fight infection. It is characterized by formation of tumors in blood-forming tissues including bone marrow. Various type of leukemia include acute lymphoblastic leukemia, acute myeloid leukemia, and chronic lymphocytic leukemia. Fatigue, weight loss, frequent infections and easy bleeding or bruising are some of the symptoms of this disease. Treatment of early leukemia include monitoring and severe leukemia is treated with chemotherapy, followed by radiation and stem-cell transplant. According to Center for Disease Control and Prevention (CDC), in the U.S. around 45,360 people were diagnosed with leukemia in 2013, leading to 23,549 fatalities (13,625 men and 9,924 women). The condition is more prevalent among men than women.

To get detailed table of content (ToC), please click: https://www.coherentmarketinsights.com/ongoing-insight/toc/528

Key players operating in the global leukemia therapeutics market include GSK, Eisai C., Pfizer, Biogen, Celgene, Novartis AG, Genzyme Corporation, Roche, and Bristol Myers Squibb Company (BMS). Major market players are focused on new product launch, product pipeline, merger & acquisitions, clinical trials and collaboration & agreements to maintain leading position in market. For instance, Novartis recently launched tyrosine kinase receptor FLT-3 for the treatment of leukemia. Pfizer implemented product expansion strategy to capture major market share, received Food and Drug Approval (FDA) for Bosulif drug.

You may be interested

Pigments Market Capacity, Production, Revenue, Price and Gross Margin, Industry Analysis and Forecast Till 2025
Business
Business

Pigments Market Capacity, Production, Revenue, Price and Gross Margin, Industry Analysis and Forecast Till 2025

Sayali Tribhuvan - July 13, 2018

Pigments Market report 2017-2025 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation,…

Nisin Industry Growth Analysis by Technology, Market drivers, and Emerging Trends Till 2025
Business
Business

Nisin Industry Growth Analysis by Technology, Market drivers, and Emerging Trends Till 2025

Sayali Tribhuvan - July 13, 2018

Nisin Market report 2017-2025 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation,…

Information Technology and Gadgets

Innovations in VR and AR in 2018

Rachel Stinson - July 12, 2018

Virtual Reality and Augmented Reality is fast becoming the order of the day if its not yet the order of the day, many organizations now use holograms…

Most from this category